
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Chronic Myelomonocytic Leukemia and Atypical Chronic Myeloid Leukemia: A National Analysis
Victoria A. Vardell, Jennifer Ose, Anton Rets, et al.
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 12, pp. 843-851
Closed Access | Times Cited: 3
Victoria A. Vardell, Jennifer Ose, Anton Rets, et al.
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 12, pp. 843-851
Closed Access | Times Cited: 3
Showing 3 citing articles:
Comprehensive Analysis of Atypical chronic myeloid leukemia (aCML): Epidemiology, Clinical Features, and Survival Outcomes Based on SEER Database Insights
Zhaoyang Hong, Fan Wang
Leukemia Research Reports (2025) Vol. 23, pp. 100505-100505
Open Access
Zhaoyang Hong, Fan Wang
Leukemia Research Reports (2025) Vol. 23, pp. 100505-100505
Open Access
SOHO State of the Art Updates and Next Questions | Atypical chronic myeloid leukemia: pathogenesis, diagnostic challenges and therapeutic strategies
Alessandro Nanni Costa, Massimo Breccia
Clinical Lymphoma Myeloma & Leukemia (2025)
Closed Access
Alessandro Nanni Costa, Massimo Breccia
Clinical Lymphoma Myeloma & Leukemia (2025)
Closed Access
SOHO State of the Art Updates and Next Questions | Atypical Chronic Myeloid Leukemia: Pathogenesis, Diagnostic Challenges, and Therapeutic Strategies
Alessandro Nanni Costa, Massimo Breccia
Clinical Lymphoma Myeloma & Leukemia (2025)
Closed Access
Alessandro Nanni Costa, Massimo Breccia
Clinical Lymphoma Myeloma & Leukemia (2025)
Closed Access